ArticleThe Lancet. Oncology2023
Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma: when and for whom?
Monika Engelhardt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleThe Lancet. Oncology2023
Monika Engelhardt et al.PubMed ↗Publisher ↗
No numbers read from the abstract.